Dr. Reddy's Laboratories, Inc. recalls
Dr. Reddy's Laboratories, Inc. is named on 19 recalls in Recall Relay's records since November 2023, from FDA (26 recalled products: FDA lists each product as its own recall); the most recent was November 11, 2025.
All 26 recalled products, newest first.
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Varenicline TabletsSub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Succinylcholine Chloride InjectionOut-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Omeprazole Delayed-release CapsulesPresence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
-
Class Iofficial
Dr. Reddy's Laboratories, Inc. recalls Levetiracetam 0.75% in Sodium Chloride Injection 1LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Javygtor (sapropterin dihydrochloride) Tablets 100mgFailed Impurities/Degradation Specifications
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls IBU (ibuprofen) 600 mg tabletsFailed Tablet/Capsule Specifications
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Morphine Sulfate Extended-Release Tablets 30 mgFailed Impurities/Degradation Specification
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Morphine Sulfate Extended-Release Tablets 15 mgFailed Impurities/Degradation Specification
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Cinacalcet TabletsCGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Sevelamer Carbonate for Oral Suspension 0.8g packetsLabeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Allopurinol TabletsPresence of foreign substance.
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Eszopiclone TabletsFailed Impurities/Degradation Specifications: Related Substances
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Zoledronic Acid Injection 5mg/100mL Sterile SolutionLack of Assurance of Sterility: Leaking vials
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Sirolimus Tablets 1mg Tablets 100-count bottleFailed Impurities/Degradation Specifications
-
Class Iofficial
Dr. Reddy's Laboratories, Inc. recalls Javygtor (sapropterin dihydrochloride) Powder for Oral Solution 100mgSub-potent Drug; powder discoloration associated with decreased potency
-
Class Iofficial
Dr. Reddy's Laboratories, Inc. recalls Sapropterin Dihydrochloride Powder for Oral Solution 100mgSub-potent Drug; powder discoloration associated with decreased potency
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Glimepiride TabletsMisprint on tablet
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Glimepiride TabletsMisprint on tablet
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Tizanidine TabletsPresence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Tacrolimus CapsulesPresence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Montelukast Sodium TabletsPresence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Dr. Reddy's Laboratories, Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts